BLOOD MONONUCLEAR-CELLS
Cytotoxic and genotoxic potential of geraniol in peripheral blood mononuclear cells and human hepatoma cell line (HepG2).
12
Viability and Functionality of Cryopreserved Peripheral Blood Mononuclear Cells in Pediatric Dengue
10
<em>USP18</em> downregulation in peripheral blood mononuclear cells predicts nonresponse to interferon-based triple therapy in patients with chronic hepatitis C, genotype 1: a pilot study
9
Nicotine Modulates the Release of Inflammatory Cytokines and Expression of TLR2, TLR4 of Cord Blood Mononuclear Cells
7
Hypoxia Pre-Conditioned Embryonic Mesenchymal Stem Cell Secretome Reduces IL-10 Production by Peripheral Blood Mononuclear Cells
8
Effect of Contaminating Red Blood Cells on OKT3-Mediated Polyclonal Activation of Peripheral Blood Mononuclear Cells
5
Ethyleneglycol-Bis-(β-Aminoethylether)Tetraacetate as a Blood Anticoagulant: Preservation of Antigen-Presenting Cell Function and Antigen-Specific Proliferative Response of Peripheral Blood Mononuclear Cells from Stored Blood
6
Intraarterial transplantation of human umbilical cord blood mononuclear cells is more efficacious and safer compared with umbilical cord mesenchymal stromal cells in a rodent stroke model
19
Gene expression signatures for autoimmune disease in peripheral blood mononuclear cells
9
Ex Vivo Stimulation and Expansion of both CD4+ and CD8+ T Cells from Peripheral Blood Mononuclear Cells of Human Cytomegalovirus-Seropositive Blood Donors by Using a Soluble Recombinant Chimeric Protein, IE1-pp65
8
Donor variability in HIV binding to peripheral blood mononuclear cells
6
Optimization of human peripheral blood mononuclear cells (PBMCs) cryopreservation
6
Zika virus infects human blood mononuclear cells
6
Platelet-activating factor changes in phospholipid extracts from the plasma, peripheral blood mononuclear cells and bone marrow mononuclear cells of patients with acute leukemia — A 31P MRS in vitro study
9
The multi-differentiation potential of peripheral blood mononuclear cells
10
Chemical and immunological characterisation of glycophospholipid and phospho-oligosaccharide from mycobacteria
246
Immunomodulatory mechanisms of lactobacilli
15
In vitro biocompatibility of calcined mesoporous silica particles and fetal blood cells
11
T-cell responses to predicted amphipathic peptides of varicella-zoster virus glycoproteins II and IV.
5
Novel immunotherapies for immune-mediated haemolytic anaemia in dogs and people
59